Edesa Biotech Inc expected to post a loss of 31 cents a share - Earnings Preview

Edesa Biotech

05/02/2025 11:02

* Edesa Biotech Inc  EDSA.OQ   EDSA.O  is expected to show
no
change in quarterly revenue when it reports  results on February
7 (estimated) for the period ending December 31 2024
    * 
    * ​LSEG's mean analyst estimate for Edesa Biotech Inc is for
a
loss of 31 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Edesa
Biotech Inc
is $20.50​, above​ its last closing price of $1.95. ​​​

This summary was machine generated February 5 at 11:01 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)